Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Weber, P.
Right arrow Articles by Portier, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weber, P.
Right arrow Articles by Portier, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 48, 291-294
© 2001 The British Society for Antimicrobial Chemotherapy


Brief report

Genetic and phenotypic characterization of macrolide resistance in group A streptococci isolated from adults with pharyngo-tonsillitis in France

P. Webera,*, J. Filipeckib, E. Bingenc, F. Fitoussic, G. Goldfarbb, J. P. Chauvinb, C. Reitzb and H. Portierd

a Laboratoire de Biologie Médicale BIO VSM, 10 rue de la Gare, F-77360 Vaires-sur-Marne; b Laboratoires Abbott, Rungis; c Service de Microbiologie, Centre Hospitalo-Universitaire Robert Debré, Paris; d Service des Maladies Infectieuses, Centre Hospitalo-Universitaire du Bocage, Dijon, France

Three hundred and three strains of group A streptococci (GAS) isolated from adults with pharyngitis were tested to evaluate their phenotype of resistance to macrolides–lincosamides and to search for macrolide resistance genes. MICs of clarithromycin were determined. The overall rate of resistance to both erythromycin and clarithromycin was 9.6%. Constitutive, inducible and M phenotypes of resistance were detected in 4.3, 2 and 3.3% of strains, respectively. All constitutive phenotypes harboured ermB genes, whereas inducible phenotypes had the ermTR gene and M phenotypes had the mefA gene. In France, the current resistance rate of GAS to erythromycin and clarithromycin remains low.

Corresponding author. Tel: +33-1-64-72-47-57; Fax: +33-1-64-72-47-58; E-mail: pweber.biovsm{at}wanadoo.fr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
D. S. Billal, M. Hotomi, J. Shimada, K. Fujihara, K. Ubukata, R. Sugita, and N. Yamanaka
Prevalence of Streptococcus Invasive Locus (sil) and Its Relationship with Macrolide Resistance among Group A Streptococcus Strains
J. Clin. Microbiol., April 1, 2008; 46(4): 1563 - 1564.
[Full Text] [PDF]


Home page
J Med MicrobiolHome page
A. Rivera, M. Rebollo, E. Miro, M. Mateo, F. Navarro, M. Gurgui, B. Mirelis, and P. Coll
Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain.
J. Med. Microbiol., August 1, 2006; 55(Pt 8): 1115 - 1123.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
C. H. W. Klaassen and J. W. Mouton
Molecular Detection of the Macrolide Efflux Gene: To Discriminate or Not To Discriminate between mef(A) and mef(E)
Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1271 - 1278.
[Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. Villedieu, M. L. Diaz-Torres, A. P. Roberts, N. Hunt, R. McNab, D. A. Spratt, M. Wilson, and P. Mullany
Genetic Basis of Erythromycin Resistance in Oral Bacteria
Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2298 - 2301.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. E. Hasenbein, J. E. Warner, K. G. Lambert, S. E. Cole, A. B. Onderdonk, and A. J. McAdam
Detection of Multiple Macrolide- and Lincosamide-Resistant Strains of Streptococcus pyogenes from Patients in the Boston Area
J. Clin. Microbiol., April 1, 2004; 42(4): 1559 - 1563.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
C. Garcia-Rey, L. Aguilar, F. Baquero, J. Casal, and J. E. Martin
Pharmacoepidemiological Analysis of Provincial Differences between Consumption of Macrolides and Rates of Erythromycin Resistance among Streptococcus pyogenes Isolates in Spain
J. Clin. Microbiol., August 1, 2002; 40(8): 2959 - 2963.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
H. Portier, J. Filipecki, P. Weber, G. Goldfarb, D. Lethuaire, and J.-P. Chauvin
Five day clarithromycin modified release versus 10 day penicillin V for group A streptococcal pharyngitis: a multi-centre, open-label, randomized study
J. Antimicrob. Chemother., February 1, 2002; 49(2): 337 - 344.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.